Description

Pharmaron Beijing Co., Ltd. is a global contract research, development, and manufacturing organization (CRDMO) that supports the life sciences sector. Operating across North America, Europe, Mainland China, and other Asian regions, the company delivers comprehensive pharmaceutical research and development services worldwide. Its diverse operations are structured into five key divisions: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Solutions; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and an "Others" category. Within its offerings, Pharmaron provides extensive laboratory support, including expertise in medicinal, synthetic, analytical, and purification chemistry, alongside computer-aided drug design. It also offers bioscience solutions such as in vitro and in vivo drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME) studies, as well as in vitro biology, in vivo pharmacology, and safety assessment, including specialized U.S. laboratory services. The company's CMC capabilities encompass process development, manufacturing, material science, pre-formulation, formulation development, manufacturing, and analytical development services. Additionally, it handles radiolabelled science and manages both early-stage clinical trials and broader clinical research with site management. Pharmaron also engages in business development and offers comprehensive contract research, development, and manufacturing for various pharmaceutical products. Established in 2004, Pharmaron Beijing Co., Ltd. is headquartered in Beijing, People's Republic of China.